← Back to Search

Procedure

Personalized Repetitive Transcranial Magnetic Stimulation for Neck Pain (PrTMS Trial)

N/A

Recruiting

Led By Oluwaseyi Gbade-Alabi, MD

Research Sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Presence of chronic neck pain for at least 3 months

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up

Awards & highlights

PrTMS Trial Summary

This trial is testing a therapy called Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) to see if it can help reduce chronic neck pain in military health system beneficiaries.

Who is the study for?

This trial is for military health system beneficiaries suffering from chronic neck pain. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions and agree to the study's procedures.Check my eligibility

What is being tested?

The effectiveness of Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) in reducing chronic neck pain is being tested. Some participants will receive PrTMS while others will get a sham treatment, which does not have any therapeutic effect, for comparison.See study design

What are the potential side effects?

While specific side effects are not listed, common ones associated with TMS may include headache, scalp discomfort at the site of stimulation, tingling or spasms of facial muscles.

PrTMS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had chronic neck pain for at least 3 months.

PrTMS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Defense & Veterans Pain Rating Scale (DVPRS)

Secondary outcome measures

Demographics Survey

Generalized Anxiety Disorder 7-item scale (GAD-7)

Insomnia Severity Index (ISI)

+10 more

PrTMS Trial Design

2Treatment groups

Experimental Treatment

Group I: Sham Personalized Repetitive Transcranial Magnetic StimulationExperimental Treatment1 Intervention

Group II: Personalized Repetitive Transcranial Magnetic StimulationExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Henry M. Jackson Foundation for the Advancement of Military MedicineLead Sponsor

92 Previous Clinical Trials

92,734 Total Patients Enrolled

Oluwaseyi Gbade-Alabi, MDPrincipal InvestigatorUniformed Services University of the Health Sciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this medical study limited to individuals aged 40 and above?

"To be eligible for this trial, individuals must meet the age requirements of being at least 18 years old and not exceeding 65 years old."

Answered by AI

Are there any current openings for participants in this ongoing trial?

"According to the information provided by clinicaltrials.gov, this specific medical trial is not currently accepting new participants. The trial was initially posted on February 1st, 2024 and received its most recent update on January 16th, 2024. However, it's worth noting that there are still a total of 78 other ongoing clinical trials actively enrolling patients at this time."

Answered by AI

What specific criteria must individuals meet to be eligible for enrollment in this clinical study?

"To be eligible for participation in this clinical trial, interested individuals should exhibit symptoms of neck pain and fall within the age range of 18 to 65. The study aims to recruit approximately 120 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)

2024. "Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06214949.

All > Neck Pain > Transcranial Magnetic Stimulation